Literature DB >> 17626099

CCR5 and CXCR3 are dispensable for liver infiltration, but CCR5 protects against virus-induced T-cell-mediated hepatic steatosis.

P J Holst1, C Orskov, K Qvortrup, J P Christensen, A R Thomsen.   

Abstract

CCR5 and CXCR3 are important molecules in regulating the migration of activated lymphocytes. Thus, the majority of tissue-infiltrating T cells found in the context of autoimmune conditions and viral infections express CCR5 and CXCR3, and the principal chemokine ligands are expressed within inflamed tissues. Accordingly, intervention studies have pointed to nonredundant roles of these receptors in models of allograft rejection, viral infection, and autoimmunity. In spite of this, considerable controversy exists, with many studies failing to support a role for CCR5 or CXCR3 in disease pathogenesis. One possible explanation is that different chemokine receptors may take over in the absence of any individual receptor, thus rendering individual receptors redundant. We have attempted to address this issue by analyzing CCR5(-/-), CXCR3(-/-), and CCR5/CXCR3(-/-) mice with regard to virus-induced liver inflammation, generation and recruitment of effector cells, virus control, and immunopathology. Our results indicate that CCR5 and CXCR3 are largely dispensable for tissue infiltration and virus control. In contrast, the T-cell response is accelerated in CCR5(-/-) and CCR5/CXCR3(-/-) mice and the absence of CCR5 is associated with the induction of CD8(+) T-cell-mediated immunopathology consisting of marked hepatic microvesicular steatosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626099      PMCID: PMC2045423          DOI: 10.1128/JVI.01242-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

Review 1.  International union of pharmacology. XXII. Nomenclature for chemokine receptors.

Authors:  P M Murphy; M Baggiolini; I F Charo; C A Hébert; R Horuk; K Matsushima; L H Miller; J J Oppenheim; C A Power
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

Review 2.  The chemokine system: redundancy for robust outputs.

Authors:  A Mantovani
Journal:  Immunol Today       Date:  1999-06

Review 3.  Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines.

Authors:  B Fromenty; D Pessayre
Journal:  J Hepatol       Date:  1997       Impact factor: 25.083

4.  Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.

Authors:  M Murai; H Yoneyama; A Harada; Z Yi; C Vestergaard; B Guo; K Suzuki; H Asakura; K Matsushima
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

5.  Recruitment of CXCR3+ and CCR5+ T cells and production of interferon-gamma-inducible chemokines in rejecting human arteries.

Authors:  William R Burns; Yinong Wang; Paul C Y Tang; Hooman Ranjbaran; Alexander Iakimov; Jinah Kim; Madison Cuffy; Yalai Bai; Jordan S Pober; George Tellides
Journal:  Am J Transplant       Date:  2005-06       Impact factor: 8.086

6.  Chemokines and the inflammatory response to viral infection in the central nervous system with a focus on lymphocytic choriomeningitis virus.

Authors:  V C Asensio; C Kincaid; I L Campbell
Journal:  J Neurovirol       Date:  1999-02       Impact factor: 2.643

Review 7.  Immunology of hepatitis B virus and hepatitis C virus infection.

Authors:  Barbara Rehermann; Michelina Nascimbeni
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

8.  Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.

Authors:  T L Sørensen; M Tani; J Jensen; V Pierce; C Lucchinetti; V A Folcik; S Qin; J Rottman; F Sellebjerg; R M Strieter; J L Frederiksen; R M Ransohoff
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

9.  Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells.

Authors:  Maureen N Ajuebor; Alex I Aspinall; Feng Zhou; Tai Le; Yang Yang; Stefan J Urbanski; Stéphané Sidobre; Mitchell Kronenberg; Cory M Hogaboam; Mark G Swain
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

10.  Virus-induced non-specific signals cause cell cycle progression of primed CD8(+) T cells but do not induce cell differentiation.

Authors:  S O Andreasen; J P Christensen; O Marker; A R Thomsen
Journal:  Int Immunol       Date:  1999-09       Impact factor: 4.823

View more
  5 in total

1.  CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells.

Authors:  Marcin Dobaczewski; Ying Xia; Marcin Bujak; Carlos Gonzalez-Quesada; Nikolaos G Frangogiannis
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

2.  CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality.

Authors:  Shaza A Fadel; Shannon K Bromley; Benjamin D Medoff; Andrew D Luster
Journal:  Eur J Immunol       Date:  2008-12       Impact factor: 5.532

3.  Chemokine receptor CXCR3 in turbot (Scophthalmus maximus): cloning, characterization and its responses to lipopolysaccharide.

Authors:  Yadong Chen; Shuhong Zhou; Zhiqiang Jiang; Xiuli Wang; Yang Liu
Journal:  Fish Physiol Biochem       Date:  2015-11-19       Impact factor: 2.794

4.  The role of CXCR3 in the induction of primary biliary cirrhosis.

Authors:  Wen Zhang; Yunyun Fei; Jinming Gao; Bin Liu; Fengchun Zhang
Journal:  Clin Dev Immunol       Date:  2011-05-02

5.  Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5.

Authors:  James G Cripps; Stela Celaj; Marie Burdick; Robert M Strieter; James D Gorham
Journal:  Lab Invest       Date:  2012-08-20       Impact factor: 5.662

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.